kabutan

RaQualia Pharma, Last Fiscal Year Ends in Surprise Net Income, The Current Fiscal Year's Net Income Turns to Loss

Fri Feb 13, 2026 3:30 pm JST Earnings

4579 RaQualia Pharma Inc. 【J-GAAP】

Earnings Report

RaQualia Pharma Inc. <4579> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The consolidated net income/loss for the fiscal year ended December 2025 turned into a profit of 273 million yen (compared to a loss of 495 million yen in the previous period), exceeding the forecast of a loss of 71 million yen loss and turning an expected deficit into a profit. For the fiscal year ending December 2026, the consolidated net income/loss is expected to turn into a loss of 63 million yen.

In the most recent three-month period, from October to December (4Q), the consolidated net income/loss turned to a profit of 841 million yen (compared to a loss of 156 million yen in the same period last year). The operating profit/loss margin drastically improved from -25.2% in the same period last year to 49.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,901 -337 -293 -323 -15.0 0 Feb 14, 2024 J-GAAP
Dec, 2024 3,107 -213 -361 -495 -22.9 0 Feb 14, 2025 J-GAAP
Dec, 2025 3,979 483 437 273 11.5 0 Feb 13, 2026 J-GAAP
YoY +28.1% － － － －

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance 3,888 118 73 -71 -2.9 0 Feb 14, 2025 J-GAAP
Dec, 2025 Results 3,979 483 437 273 11.5 0 Feb 13, 2026 J-GAAP
Revision Rate +2.3% +309.3% +498.6% － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 1,535 -190 -291 -354 -15.5 0 Aug 14, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 3,107 -213 -361 -495 -22.9 0 Feb 14, 2025 J-GAAP
Dec, 2025 3,979 483 437 273 11.5 0 Feb 13, 2026 J-GAAP
Dec, 2026 Guidance 3,980 165 86 -63 -2.4 0 Feb 13, 2026 J-GAAP
YoY +0.0% -65.8% -80.3% － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 738 -186 -130 -156 -7.2 -25.2 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 965 93 29 -5 -0.2 9.6 May 15, 2025 J-GAAP
Apr - Jun, 2025 570 -283 -320 -349 -15.3 -49.6 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 776 -154 -135 -214 -9.2 -19.8 Nov 14, 2025 J-GAAP
Oct - Dec, 2025 1,668 827 863 841 35.5 49.6 Feb 13, 2026 J-GAAP
YoY +126.0% － － － －

Related Articles